Exploring health benefits of natural compounds
Beneficial Exposome: Investigating Its Effect on Human Health
This study is testing whether being around natural compounds can improve people's overall health, including their mood, stress levels, and sleep quality.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Stanford University Academic / other |
| Locations | 1 site (Palo Alto, California) |
| Trial ID | NCT06093464 on ClinicalTrials.gov |
What this trial studies
This study investigates the positive health outcomes associated with regular exposure to naturally occurring compounds, focusing on their potential benefits for holistic human health. Researchers will analyze blood specimens to measure biomarkers such as cortisol and inflammatory markers, while also utilizing wearable sensors to assess cardiovascular health and sleep quality. Participants will complete surveys to evaluate their well-being, stress levels, and mood. The goal is to understand how intentional exposure to these compounds can influence overall health.
Who should consider this trial
Good fit: Ideal candidates for this study are healthy adults aged 18 and older who can understand and communicate in English.
Not a fit: Patients who are pregnant, breastfeeding, or have specific allergies or cognitive impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into how natural compounds can enhance overall health and well-being.
How similar studies have performed: While there has been extensive research on harmful environmental exposures, studies focusing on beneficial exposomes are less common, making this approach relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years of age and older * Read, speak, and understand English * Live in the US territory Exclusion Criteria: * Mental incapacity and/or cognitive impairment on the part of the patient that would preclude adequate understanding of, or cooperation with, the study protocol * Is pregnant * Is breastfeeding * Has epilepsy * Has allergies to Cupressaceae family of plants, common plants include redwoods, junipers, cypress, cedar, fir, and sequoia
Where this trial is running
Palo Alto, California
- Stanford University — Palo Alto, California, United States (Recruiting)
Study contacts
- Principal investigator: Michael Snyder, PhD — Stanford University
- Study coordinator: Ji Hyun Kim, MS
- Email: jikimji@stanford.edu
- Phone: (650) 441-6216
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.